531 related articles for article (PubMed ID: 26058042)
1. Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
Seimetz M; Parajuli N; Pichl A; Bednorz M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Weissmann N
PLoS One; 2015; 10(6):e0129327. PubMed ID: 26058042
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of soluble guanylate cyclase stimulation on pulmonary hemodynamics and emphysema development in guinea pigs chronically exposed to cigarette smoke.
Paul T; Blanco I; Aguilar D; Tura-Ceide O; Bonjoch C; Smolders VF; Peinado VI; Barberà JA
Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L222-L234. PubMed ID: 31166128
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.
Weissmann N; Lobo B; Pichl A; Parajuli N; Seimetz M; Puig-Pey R; Ferrer E; Peinado VI; Domínguez-Fandos D; Fysikopoulos A; Stasch JP; Ghofrani HA; Coll-Bonfill N; Frey R; Schermuly RT; García-Lucio J; Blanco I; Bednorz M; Tura-Ceide O; Tadele E; Brandes RP; Grimminger J; Klepetko W; Jaksch P; Rodriguez-Roisin R; Seeger W; Grimminger F; Barberà JA
Am J Respir Crit Care Med; 2014 Jun; 189(11):1359-73. PubMed ID: 24738736
[TBL] [Abstract][Full Text] [Related]
4. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.
Seimetz M; Parajuli N; Pichl A; Veit F; Kwapiszewska G; Weisel FC; Milger K; Egemnazarov B; Turowska A; Fuchs B; Nikam S; Roth M; Sydykov A; Medebach T; Klepetko W; Jaksch P; Dumitrascu R; Garn H; Voswinckel R; Kostin S; Seeger W; Schermuly RT; Grimminger F; Ghofrani HA; Weissmann N
Cell; 2011 Oct; 147(2):293-305. PubMed ID: 22000010
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis.
Vij N; Chandramani-Shivalingappa P; Van Westphal C; Hole R; Bodas M
Am J Physiol Cell Physiol; 2018 Jan; 314(1):C73-C87. PubMed ID: 27413169
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of caveolin-1 during pathogenesis of combined pulmonary fibrosis and emphysema: Effect of phosphodiesterase-5 inhibitor.
Kulshrestha R; Singh H; Pandey A; Soundarya D; Jaggi AS; Ravi K
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165802. PubMed ID: 32311453
[TBL] [Abstract][Full Text] [Related]
8. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke.
Martorana PA; Beume R; Lucattelli M; Wollin L; Lungarella G
Am J Respir Crit Care Med; 2005 Oct; 172(7):848-53. PubMed ID: 15961691
[TBL] [Abstract][Full Text] [Related]
9. Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
Perez M; Lee KJ; Cardona HJ; Taylor JM; Robbins ME; Waypa GB; Berkelhamer SK; Farrow KN
PLoS One; 2017; 12(8):e0180957. PubMed ID: 28792962
[TBL] [Abstract][Full Text] [Related]
10. 3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats.
Lan TH; Chen XL; Wu YS; Qiu HL; Li JZ; Ruan XM; Xu DP; Lin DQ
Eur J Pharmacol; 2018 Jun; 829():102-111. PubMed ID: 29665366
[TBL] [Abstract][Full Text] [Related]
11. Time-course effects of aerobic physical training in the prevention of cigarette smoke-induced COPD.
Toledo-Arruda AC; Vieira RP; Guarnier FA; Suehiro CL; Caleman-Neto A; Olivo CR; Arantes PMM; Almeida FM; Lopes FDTQS; Ramos EMC; Cecchini R; Lin CJ; Martins MA
J Appl Physiol (1985); 2017 Sep; 123(3):674-683. PubMed ID: 28729393
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice.
Sato A; Hoshino Y; Hara T; Muro S; Nakamura H; Mishima M; Yodoi J
J Pharmacol Exp Ther; 2008 May; 325(2):380-8. PubMed ID: 18256171
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4.
Nose T; Kondo M; Shimizu M; Hamura H; Yamaguchi Y; Sekine T; Ishitani K
Biol Pharm Bull; 2016; 39(5):689-98. PubMed ID: 27150141
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of Cigarette Smoke-Induced Emphysema in Mice by Apolipoprotein A-1 Overexpression.
Kim C; Lee JM; Park SW; Kim KS; Lee MW; Paik S; Jang AS; Kim DJ; Uh S; Kim Y; Park CS
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):91-102. PubMed ID: 26086425
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
de Visser YP; Walther FJ; Laghmani el H; Steendijk P; Middeldorp M; van der Laarse A; Wagenaar GT
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L56-67. PubMed ID: 21949154
[TBL] [Abstract][Full Text] [Related]
17. Effects of tadalafil (PDE5 inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in guinea pigs.
Mokry J; Urbanova A; Medvedova I; Kertys M; Mikolka P; Kosutova P; Mokra D
J Physiol Pharmacol; 2017 Oct; 68(5):721-730. PubMed ID: 29375047
[TBL] [Abstract][Full Text] [Related]
18. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological profile of roflumilast].
Cortijo Gimeno J; Morcillo Sánchez E
Arch Bronconeumol; 2010 Dec; 46 Suppl 10():19-24. PubMed ID: 21316552
[TBL] [Abstract][Full Text] [Related]
20. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
